US Stock MarketDetailed Quotes

BPMC Blueprint Medicines

Watchlist
  • 86.000
  • 0.0000.00%
Close Oct 18 16:00 ET
  • 86.000
  • 0.0000.00%
Post 17:16 ET
5.45BMarket Cap-25219P/E (TTM)

Blueprint Medicines Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Blueprint Medicines Q3 2024 Estimates Date

Currency：USDOct 30, 2024

Estimate YoY
Revenue
127.73M
+125.82%
EPS
-0.97
+55.77%
Analyst Rating
Strong Buy

Oct 19, 2024

Blueprint Medicines Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 14 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 138.793M--
Oct 30, 20242024/Q3-- / 127.735M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q4-- / 138.793M--
Oct 30, 20242024/Q3-- / 127.735M--
Aug 1, 20242024/Q2138.157M / 103.938M--
May 2, 20242024/Q196.116M / 81.445M--
Feb 15, 20242023/Q471.957M / 67.103M--

Unlock Free Earnings Estimates

Blueprint Medicines Earnings Reports

  • Blueprint Medicines | 10-Q: Q2 2024 Earnings Report

    Aug 1 16:52 ET

  • Blueprint Medicines | 10-Q: Q1 2024 Earnings Report

    May 2 16:51 ET

  • Blueprint Medicines | 10-K: FY2023 Annual Report

    Feb 15 22:20 ET

  • Blueprint Medicines | 10-Q: Q3 2023 Earnings Report

    Oct 26, 2023 16:01 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Oct 19, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data

    Concept Cancer Research
    Cancer Research
    Intraday-0.18%